Bepridil
Back to searchMolecule Structure
Scientific Name
Bepridil
Description of the Drug
Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01244
http://www.drugbank.ca/drugs/DB01244
Brand Name(s)
Not Available
Company Owner(s)
Medpointe Pharmaceuticals Medpointe Healthcare Inc, Johnson And Johnson Pharmaceutical Research And Development Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Voltage-gated calcium channel | PROTEIN COMPLEX GROUP | BLOCKER | CHEMBL2363032 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL34412 | ||
PharmGKB | PA164754755 | ||
Human Metabolome Database | HMDB0015374 | ||
DrugBank | DB01244 | ||
PubChem: Thomson Pharma | 14755108 | ||
PubChem | 2351 | ||
Mcule | MCULE-3001828285 | ||
LINCS | LSM-1898 | ||
Nikkaji | J558.970C | J19.767J | |
BindingDB | 78577 | ||
EPA CompTox Dashboard | DTXSID3022663 | ||
DrugCentral | 342 | ||
Brenda | 66183 | 229198 | 229199 |
ChemicalBook | CB5212202 | ||
Guide to Pharmacology | 2337 | ||
rxnorm | BEPRIDIL HYDROCHLORIDE | BEPRIDIL | |
KEGG Ligand | C06847 | ||
ChEBI | 3061 |